Dicot Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 24, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	691	431	260	46	71	46	Upgrade
Market Cap Growth	65.92%	65.92%	464.37%	-35.49%	56.49%	-0.03%	Upgrade
Enterprise Value	578	421	215	32	54	28	Upgrade
Last Close Price	0.34	0.24	0.32	0.34	0.69	1.04	Upgrade
PB Ratio	6.19	3.86	5.86	8.60	2.52	2.32	Upgrade
P/TBV Ratio	6.19	3.86	5.86	8.60	2.52	2.32	Upgrade
Quick Ratio	9.78	9.78	5.42	1.50	9.16	10.88	Upgrade
Current Ratio	10.34	10.34	5.84	1.76	9.28	11.06	Upgrade
Return on Equity (ROE)	-73.94%	-73.94%	-177.51%	-188.41%	-113.20%	-108.08%	Upgrade
Return on Assets (ROA)	-41.82%	-41.82%	-85.39%	-90.05%	-63.81%	-61.53%	Upgrade
Return on Capital (ROIC)	-47.48%	-47.48%	-113.15%	-117.93%	-70.95%	-67.64%	Upgrade
Earnings Yield	-8.35%	-13.38%	-16.98%	-68.93%	-38.05%	-38.44%	Upgrade
FCF Yield	-	-13.65%	-17.40%	-64.50%	-36.22%	-35.71%	Upgrade
Buyback Yield / Dilution	-105.97%	-105.97%	-336.53%	-89.21%	-124.32%	-187.81%	Upgrade

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.